119 related articles for article (PubMed ID: 19896186)
1. CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: proposal for an accelerated diagnostic flowchart.
Gandemer V; Aubry M; Roussel M; Rio AG; de Tayrac M; Vallee A; Mosser J; Ly-Sunnaram B; Galibert MD
Leuk Res; 2010 Apr; 34(4):430-7. PubMed ID: 19896186
[TBL] [Abstract][Full Text] [Related]
2. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
[TBL] [Abstract][Full Text] [Related]
3. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
Peter A; Heiden T; Taube T; Körner G; Seeger K
Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
5. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.
Tiensiwakul P
Cancer Genet Cytogenet; 2004 Feb; 149(1):85-8. PubMed ID: 15104290
[TBL] [Abstract][Full Text] [Related]
6. Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization.
Tsuzuki S; Karnan S; Horibe K; Matsumoto K; Kato K; Inukai T; Goi K; Sugita K; Nakazawa S; Kasugai Y; Ueda R; Seto M
Cancer Sci; 2007 May; 98(5):698-706. PubMed ID: 17374122
[TBL] [Abstract][Full Text] [Related]
7. TEL/AML1-positive patients lacking TEL exon 5 resemble canonical TEL/AML1 cases.
Zaliova M; Meyer C; Cario G; Vaskova M; Marschalek R; Stary J; Zuna J; Trka J
Pediatr Blood Cancer; 2011 Feb; 56(2):217-25. PubMed ID: 21157892
[TBL] [Abstract][Full Text] [Related]
8. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
[TBL] [Abstract][Full Text] [Related]
10. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
[TBL] [Abstract][Full Text] [Related]
11. TEL/AML1 and immunoreceptor gene rearrangements-which comes first?
Zuna J; Krejci O; Madzo J; Fronkova E; Sramkova L; Hrusak O; Kalina T; Vaskova M; Stary J; Trka J;
Leuk Res; 2005 Jun; 29(6):633-9. PubMed ID: 15863202
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
[TBL] [Abstract][Full Text] [Related]
13. [Study of TEL-AML1 fusion gene in childhood B-lineage acute lymphoblastic leukemia].
Niu C; Huang W; Su X
Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):61-4. PubMed ID: 11601199
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of patients with TEL-AML1-positive acute lymphoblastic leukemia with single or multiple fusions.
Al-Sweedan SA; Neglia JP; Steiner ME; Bostrom BC; Casey T; Hirsch BA
Pediatr Blood Cancer; 2007 May; 48(5):510-4. PubMed ID: 16763978
[TBL] [Abstract][Full Text] [Related]
15. Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California.
McHale CM; Wiemels JL; Zhang L; Ma X; Buffler PA; Guo W; Loh ML; Smith MT
Genes Chromosomes Cancer; 2003 May; 37(1):36-43. PubMed ID: 12661004
[TBL] [Abstract][Full Text] [Related]
16. The presence of TEL/AML1 rearrangement and cryptic deletion of the TEL gene in adult acute lymphoblastic leukemia (ALL).
Lee DS; Kim YR; Cho HK; Lee CK; Lee JH; Cho HI
Cancer Genet Cytogenet; 2005 Oct; 162(2):176-8. PubMed ID: 16213368
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
Schmidt K; Seeger K; Scheibenbogen C; Bender R; Abdulla M; Süssmilch S; Salama A; Moldenhauer A
J Leukoc Biol; 2009 Mar; 85(3):563-73. PubMed ID: 19129484
[TBL] [Abstract][Full Text] [Related]
18. Childhood leukemia genetic bottleneck phenomenon related to TEL-AML1: the postulation by a mathematical model.
Ivanovski P; Ivanovski I; Nikolić D; Jovanović I
Chin Med J (Engl); 2012 Mar; 125(6):1182-5. PubMed ID: 22613552
[TBL] [Abstract][Full Text] [Related]
19. Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
Seeger K; Kreuzer KA; Lass U; Taube T; Buchwald D; Eckert C; Körner G; Schmidt CA; Henze G
Cancer Res; 2001 Mar; 61(6):2517-22. PubMed ID: 11289124
[TBL] [Abstract][Full Text] [Related]
20. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]